
Subhrab D 30mg/40mg Capsule SR
Marketer
Subhyog Pharmaceutical Private Limited
Salt Composition
Domperidone (30mg) + Pantoprazole (40mg)
Overview Subhrab D 30mg/40mg Capsule SR
Subhrab D 30mg/40mg SR capsules are a prescription medication indicated for gastroesophageal reflux disease (GERD), indigestion (dyspepsia), and gastritis. Its mechanism involves acid reduction within the stomach, providing relief from associated symptoms like heartburn, stomach upset, and pain. This medication also neutralizes stomach acid and facilitates gas expulsion, easing discomfort. Administer as directed by your physician, on an empty stomach, for the prescribed duration and dosage. Dosage is individualized based on your condition and response. Discontinue only as advised; premature cessation may lead to symptom recurrence and condition exacerbation. Inform your healthcare provider of all concurrent medications, as interactions may occur. Common side effects include diarrhea, vomiting, abdominal pain, flatulence, dry mouth, and headache—most are transient. Report any concerning side effects immediately. Drowsiness and dizziness are possible; avoid driving or activities demanding alertness until the effects are known. Alcohol consumption should be avoided due to potential additive drowsiness. Lifestyle adjustments, such as consuming cold milk and avoiding caffeinated beverages, spicy foods, and chocolate, can enhance treatment outcomes. Prior to commencing treatment, disclose any existing kidney or liver conditions, pregnancy, pregnancy planning, or breastfeeding to your physician.
Uses of Subhrab D 30mg/40mg Capsule SR
Managing gastroesophageal reflux, indigestion, and gastritis.
Major Benefits of Subhrab D 30mg/40mg Capsule SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire capsule without chewing, crushing, or breaking it. Subhrab D 30mg/40mg Sustained-Release Capsules should be taken on an empty stomach.
Common Side effects of Subhrab D 30mg/40mg Capsule SR:
- Diarrhea
- Stomach pain
- Flatulence
- Dryness in mouth
- Dizziness
- Headache
How to use Subhrab D 30mg/40mg Capsule SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Subhrab D 30mg/40mg SR Capsules. Ingest the capsules whole; avoid chewing, crushing, or breaking them. Administer this medication on an empty stomach.
How Subhrab D 30mg/40mg Capsule SR works:
Subhrab D SR capsules (30mg/40mg) contain Domperidone and Pantoprazole, working synergistically to alleviate digestive discomfort. Domperidone, a prokinetic agent, enhances gastric motility, facilitating efficient food passage. Pantoprazole, a proton pump inhibitor (PPI), decreases stomach acid production, providing relief from acid indigestion and heartburn.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Subhrab D 30mg/40mg Capsule SR concurrently with alcohol. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Subhrab D 30mg/40mg SR Capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against any possible risks prior to prescribing this medication. Medical advice is recommended.
Breast feedingCAUTION
Subhrab D 30mg/40mg sustained-release capsules require careful consideration when breastfeeding. Mothers should cease breastfeeding throughout their treatment course and until the medication is fully cleared from their system.
DrivingUNSAFE
Taking Subhrab D 30mg/40mg sustained-release capsules might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Subhrab D 30mg/40mg sustained-release capsules. Dosage modifications for Subhrab D 30mg/40mg sustained-release capsules may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Subhrab D 30mg/40mg Capsule SR in patients with liver disease appears to pose minimal risk. Current evidence indicates dose modification may not be necessary, however, physician consultation is recommended.
What if you forget to take Subhrab D 30mg/40mg Capsule SR :
Should you forget to take your Subhrab D 30mg/40mg SR Capsule, administer it immediately. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Subhrab D 30mg/40mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal system |
